首页 | 本学科首页   官方微博 | 高级检索  
     


Comorbidities in Psoriatic Arthritis
Affiliation:1. Probity Medical Research, Waterloo, Ontario, Canada;2. Dermatologikum Hamburg, Hamburg, Germany;3. Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri;11. Mount Sinai Medical Center, New York, New York;4. Physicians Skin Care, PLLC, Louisville, Kentucky;5. University of Rome Tor Vergata, Rome, Italy;6. Dalhousie University, Halifax, Nova Scotia, Canada;7. Celgene Corporation, Summit, New Jersey;8. Northwestern University, Chicago, Illinois;9. University Hospitals Case Medical Center, Cleveland, Ohio;10. Dermatology Center, Salford Royal Hospital, University of Manchester, Manchester, United Kingdom;1. Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany;2. Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri;3. Division of Clinical Dermatology and Cutaneous Science, Dallhousie University, Halifax, Nova Scotia, Canada;4. Dermatology Centre, Salford Royal Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom;5. Sorbonne Paris Cité Université Paris Diderot, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherché 1163, Imagine Institute, Necker Hospital, Paris, France;6. Department of Dermatology Hospital das Clínicas University of São Paulo, São Paulo, Brazil;7. Jichi Medical University, Shimotsuke, Japan;8. Eli Lilly and Company, Indianapolis, Indiana;9. Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York;1. Immunoregulation Laboratory, Research Centre of University of Montreal Hospital, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada;2. Columbia Center for Translational Immunology (CCTI), Columbia University Medical Center (CUMC), New York, New York, USA;3. Immunology, Janssen Research & Development, LLC, San Diego, California, USA;4. Innovaderm Research, Montreal, Quebec, Canada;5. Center for Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;6. Oregon Medical Research Center, Portland, Oregon, USA;1. Department of Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;2. Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;3. Clinical Research Management Center, Nagoya City University Hospital, Nagoya, Japan;4. Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan;5. Laboratory for Immune Regulation, World Premier International Research Center Initiative, Immunology Frontier Research Center, Osaka University, Osaka, Japan;1. Faculty of Medicine, Health Sciences Centre, Memorial University of Newfoundland, 300 Prince Philip Drive, Room 1J440, St. John’s, Newfoundland and Labrador A1B 3V6, Canada;2. St. Clare’s Mercy Hospital, Memorial University of Newfoundland, 154 Le Marchant Road, St. John’s, Newfoundland and Labrador A1C 5B8, Canada
Abstract:
Keywords:Psoriatic arthritis  Comorbidity  Psoriasis  Management  Screening
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号